PDT Partners’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-102,516
| Closed | -$733K | – | 818 |
|
|
2025
Q1 | $733K | Buy |
102,516
+39,501
| +63% | +$282K | 0.05% | 451 |
|
|
2024
Q4 | $487K | Buy |
+63,015
| New | +$487K | 0.04% | 489 |
|
|
2024
Q3 | – | Sell |
-34,412
| Closed | -$403K | – | 804 |
|
|
2024
Q2 | $403K | Buy |
34,412
+25
| +0.1% | +$292 | 0.04% | 512 |
|
|
2024
Q1 | $725K | Buy |
+34,387
| New | +$725K | 0.07% | 387 |
|
|
2022
Q4 | – | Sell |
-8,906
| Closed | -$235K | – | 852 |
|
|
2022
Q3 | $235K | Sell |
8,906
-6,479
| -42% | -$171K | 0.04% | 667 |
|
|
2022
Q2 | $380K | Buy |
15,385
+1,360
| +10% | +$33.6K | 0.03% | 682 |
|
|
2022
Q1 | $465K | Buy |
14,025
+3,025
| +28% | +$100K | 0.04% | 609 |
|
|
2021
Q4 | $360K | Buy |
+11,000
| New | +$360K | 0.03% | 625 |
|
|
2021
Q3 | – | Sell |
-50,331
| Closed | -$1.96M | – | 888 |
|
|
2021
Q2 | $1.96M | Sell |
50,331
-13,646
| -21% | -$530K | 0.13% | 272 |
|
|
2021
Q1 | $2.18M | Buy |
63,977
+18,987
| +42% | +$648K | 0.16% | 255 |
|
|
2020
Q4 | $2.04M | Sell |
44,990
-18,333
| -29% | -$832K | 0.14% | 247 |
|
|
2020
Q3 | $1.74M | Buy |
63,323
+41,657
| +192% | +$1.15M | 0.12% | 228 |
|
|
2020
Q2 | $798K | Buy |
+21,666
| New | +$798K | 0.05% | 318 |
|
|
2018
Q3 | – | Sell |
-42,946
| Closed | -$3.08M | – | 530 |
|
|
2018
Q2 | $3.08M | Buy |
42,946
+13,100
| +44% | +$940K | 0.12% | 203 |
|
|
2018
Q1 | $891K | Buy |
+29,846
| New | +$891K | 0.03% | 364 |
|